AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...
And by the end of the decade, J&J is expecting double-digit annual growth, said CEO Joaquin Duato on an analysts' call.
4don MSN
AbbVie targets $24B in 2025 sales from Skyrizi and Rinvoq, outlines robust mid-single-digit growth
CEO Rob Michael highlighted AbbVie's strong Q4 2024 performance, which exceeded initial guidance with $56.3 billion in total ...
Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
Fast Five Quiz: Molecular and Biomarker Analysis in NSCLC How much do you know about molecular and biomarker analysis in non-small cell lung cancer? Test your knowledge with this quick quiz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results